Adiana
Contraceptive device developer completes $23M financing
Published in Law and Health Weekly, September 24th, 2005
In addition to Adiana's current investors, OrbiMed Advisors LLC participated as a new investor. The company also announced that Joan P. Neuscheler of Tullis-Dickerson and Jonathan T. Silverstein, JD, of OrbiMed will join its board of directors.
"These funds will allow us to complete our clinical trial, obtain regulatory approval, and prepare for market launch next year," said Paul Goeld, Adiana's president and CEO. "We are particularly excited by the investments from Tullis-Dickerson and OrbiMed, world-class...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Beth Israel Deaconess Medical Center, Boston
CD8+ depletion reduced virus levels of virus in SIV-vaccinated macaques - Chiron Corp.
Priming-boosting regimen enhance plasmid DNA microparticle HIV vaccines - Chiron Corporation
Research add new data to HIV/AIDS vaccines body of knowledge - Ciphergen Biosystems
University of Kentucky, biomarker research firm partner to fight ovarian cancer - Crucell Holland BV
Vectors from rare adenovirus serotypes may be useful for vaccines - Cytos Biotechnology
Company awarded patent for Immunodrugs to treat addiction - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
